The clinical effectiveness and medical costs of nationwide insurance coverage for next-generation sequencing in advanced ovarian cancer: a nationwide population-based real-world data study

MLA

Dong-Won Kang, et al. “The Clinical Effectiveness and Medical Costs of Nationwide Insurance Coverage for Next-Generation Sequencing in Advanced Ovarian Cancer: A Nationwide Population-Based Real-World Data Study.” Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology, Jan. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........76e3e6ffa57f83dfd9affeb888aaee2a&authtype=sso&custid=ns315887.

APA

Dong-Won Kang, Sun-Kyeong Park, Ye Lee Yu, & Sokbom Kang. (2023). The clinical effectiveness and medical costs of nationwide insurance coverage for next-generation sequencing in advanced ovarian cancer: a nationwide population-based real-world data study. Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology.

Chicago

Dong-Won Kang, Sun-Kyeong Park, Ye Lee Yu, and Sokbom Kang. 2023. “The Clinical Effectiveness and Medical Costs of Nationwide Insurance Coverage for Next-Generation Sequencing in Advanced Ovarian Cancer: A Nationwide Population-Based Real-World Data Study.” Proceedings of the 38th Annual Meeting of Korean Society of Gynecologic Oncology, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........76e3e6ffa57f83dfd9affeb888aaee2a&authtype=sso&custid=ns315887.